1 |
Lack of renal recovery predicts poor survival in patients of Multiple Myeloma with renal impairment |
|
| | Rintu Sharma, Arihant Jain, Aditya Jandial, Deepesh Lad, Alka Khadwal, Gaurav Prakash, Ritambhra Nada, Ritu Aggarwal, Raja Ramachandran, Neelam Varma, Pankaj Malhotra | | | Clinical Lymphoma Myeloma and Leukemia. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
A Prospective Single-Arm Study of Melphalan, Prednisolone and Lenalidomide (MPL) as First Line Treatment in Elderly Patients with Multiple Myeloma – An Institutional Study |
|
| | Haridas K. Lakshmi, Geetha Narayanan, Shahid P. P. Abdul, G. Nair Sreejith | | | Indian Journal of Medical and Paediatric Oncology. 2022; 43(05): 409 | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
Radiomic analysis of positron-emission tomography and computed tomography images to differentiate between multiple myeloma and skeletal metastases |
|
| | Pallavi Mannam, Arunan Murali, Periakaruppan Gokulakrishnan, Easwaramoorthy Venkatachalapathy, PulivadulaMohanarangam Venkata Sai | | | Indian Journal of Nuclear Medicine. 2022; 37(3): 217 | | | [Pubmed] [Google Scholar] [DOI] | | 4 |
Multiple myeloma: Unveiling the survival data with different lines of treatments |
|
| | Helan Kurian, Suja Abraham, Arpith Antony, JeevaAnn Jiju, Timy Thomas | | | Journal of Cancer Research and Therapeutics. 2022; 0(0): 0 | | | [Pubmed] [Google Scholar] [DOI] | |
|